ARTICLE | Clinical News
Biovail Corp. International regulatory update
July 29, 1996 7:00 AM UTC
BVF received U.S. Patent No. 5,529,791 covering an extended release drug delivery system for the hypertension drug Diltiazem. The patent covers beads containing Diltiazem and a wetting agent coated wi...